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Abstract
Objective—Although colorectal cancer (CRC) mortality rates in the US population have shown a
decline, American Indian (AI) CRC mortality rates appear to be increasing. CRC screening rates
of AIs remain low when compared with other ethnic groups. The research team explored women's
perceptions toward CRC screening, existing barriers, and suggestions to promote education and
screening among AI women in Kansas and Missouri.
Methods—Using a community-based participatory research approach, the authors conducted 7
focus groups with AI women older than 50 years (N = 52) to better understand their perceptions of
and attitudes toward CRC screening.
Results—Women recognized barriers to screening, such as embarrassment, privacy issues, fear,
insurance, and cost. They countered perceived barriers through inventive suggestions for
education and awareness via social support systems and intergenerational relationships.
Discussion—CRC screening interventions for AI must be culturally tailored.
Keywords
American Indian; colorectal cancer; colorectal cancer screening; community-based participatory
research
In the United States, colorectal cancer (CRC) is the second leading cause of cancer death for
men and women combined.1 Some data sources, such as the Surveillance, Epidemiology,
and End Results (SEER) program report that American Indians/Alaska Natives (AI/AN)
have lower CRC incidence rates than both white and black americans.2 However, SEER data
focus on AI/AN in selected geographic areas and increasingly suggest that there are wide
variations in CRC incidence rates by region.3 Disproportionately higher rates of CRC
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incidence have been reported for AN (102.6/100 000), and for AI in the Northern (54.9/100
000) and Southern Plains (49.1/100 000).3,4 Coupled with this, stage of CRC diagnosis is
higher and survival is lower for AI/AN populations, even when adjusted for socioeconomic
differences.5 Some reports show that CRC mortality rates are rising for the AI/ AN
population,6 opposite of a national trend of decreasing CRC mortality among the overall US
population. The regional variation, substantial misclassification of AI/AN race in many
cancer registries,7 and poorer survival once diagnosed demonstrate that CRC burden in AI/
AN may be underestimated and represents a significant public health problem.
Screening for CRC is an effective strategy for reducing incidence and mortality.8-10
Screening can detect cancers at early stages when treatment is more effective (ie, improving
survival and reducing mortality) and can lead to detection and removal of premalignant
growths, thereby reducing CRC incidence. Screening is low in the general US population
and lower still among AI/AN.11-13 Lower screening rates among AI/AN are associated with
later stage at diagnosis and poorer outcomes.14 Current CRC screening rates for all race/
ethnic US women are reported around 11.7% for fecal occult blood test (FOBT), 42% for
sigmoidoscopy or colonoscopy, and 45.8% for combined endoscopy/FOBT.1 For AI/AN
women, these rates are 5.8%, 31.7%, and 34.4%, respectively.1 A number of well-
established patient-level and system-level barriers to CRC screening exist, but few studies
have investigated barriers to or facilitators of CRC screening among AI/AN. This is
important because in addition to socioeconomic factors, there may be culturally specific
barriers to and facilitators of screening, such as speaking a Native language15 or perceiving
discrimination in medical settings.16,17 This study was designed to explore the perceptions
of AI women older than 50 years toward CRC screenings, existing barriers, and suggestions
to promote education and screening among AI in the Midwest.
Methods
To understand women's perceptions of CRC screenings, existing barriers, and suggestions to
promote education and screening among AI women in Kansas and Missouri, we conducted a
series of 7 focus groups with women 50 years and older (N = 52 participants). Participants
were recruited primarily through word-of-mouth at local powwows and other cultural
events. Additional recruitment was done through posters and flyers at locations AI women
frequent, e-mail listservs from community organizations, and direct recruitment through our
community advisory board. All study protocols were approved by the University of Kansas
Medical Center Human Subjects Committee and local tribal councils, as needed.
A focus group moderator's guide was developed in conjunction with a community advisory
board, based on prior interviews with community leaders and providers18 (see the appendix).
Focus groups were held in both urban areas and on reservations during both days and
evenings to accommodate women with various work schedules. Groups lasted between 60
and 90 minutes and were audio-taped and transcribed verbatim. New groups were convened
until data saturation was achieved on major themes. Text analysis was conducted using a
community-based participatory research protocol developed by the team where 5 individuals
are involved in analysis, 3 as coders (2 researchers and 1 community member) and 2 as
reviewers of themes developed by the coders (the study principal investigator [PI] and 1
community member). Transcripts were coded independently by hand by 3 members of the
research team using a codebook developed by both academic and community member
researchers specifically for this study using an inductive approach. Approximately 10% of
the codes were cross-checked by the PI of the overall study to ensure intercoder reliability;
few to no differences were found. Coders identified preliminary themes that were then
combined into thematic statements by the PI and checked by a community member
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researcher. The entire team then met to ensure consensus on the final themes. Full details of
the analytic process are described elsewhere.19
Results
We conducted 7 focus groups with AI women; demographic information is summarized in
Table 1 and screening history in Table 2. Text analysis of focus group data revealed 7
discrete themes.
Women had general knowledge of CRC symptoms, screening methods, risk factors, and
treatment. Sources of knowledge included TV personalities, Internet sites, providers, family
and friends, and tribal newspapers. Some participants had been screened or had indirect
experience with CRC, so they had knowledge of the process and knew more than those who
had not. Other women said that their knowledge was superficial. For example, women may
have heard of different screening tests but did not know their importance or the pros and
cons of each.
Women described hearing about CRC screening via various media. Television personalities
such as Oprah, Dr Oz, and Katie Couric, were cited as vehicles for providing information
about CRC. Participants named other sources for CRC information, such as the Internet and
print materials, though none referred to specific sources.
Health care providers and family members or friends were described as providing
information from a clinical or experiential perspective. Most women stated that their health
care providers had recommended and discussed screenings with them, providing basic
information. Family and friends provided information about prior experiences with CRC
screening. Even though women's exposure to CRC information varied, most agreed that the
information they received from health care providers, family, and friends lacked details
specific to AI.
Women felt that Native people do not get screened for CRC; barriers to screening included
embarrassment, privacy issues, fear of the procedure and possible results, insurance, and
cost. Embarrassment was mentioned by many women who explained that colonoscopy
involves body parts that may not be discussed openly. Some participants suggested that the
colon, and the colonoscopy, are somewhat taboo and are not talked about because of
privacy.
Other participants discussed fear, both of the tests themselves and of the results, as factors
that would inhibit them from getting screened. Women mentioned factors that influenced
their uncertainty toward the process, such as not knowing what to expect, how the procedure
would feel, and what to do beyond the screening (depending on the outcome). Others
described hearing from friends about difficulties preparing for and receiving colonoscopies.
However, most women who had received colonoscopies reported it was not a big deal or
that although it may not have been pleasant, the benefits outweighed the uncomfortable or
awkward process. The same was true for FOBT. Even though FOBT is noninvasive, some
women felt that the collection of stool was disgusting and that they did not want to do it.
Women who had an FOBT screening stated that the test may not be desirable, but the
alternative of doing nothing was worse.
Finally, participants listed both lack of insurance and cost as barriers to screenings.
Participants felt that if a screening detected something suspicious or abnormal, the necessary
follow-up and treatment could be problematic in the absence of insurance. In addition,
women reported that many AI do not have insurance outside of the Indian Health Service
(IHS) and, therefore, would have difficulty accessing a colonoscopy. Participants stated that
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the IHS in Kansas does not provide screening colonoscopies and that AIs without health
insurance have to pay for colonoscopies out of pocket. Furthermore, participants reported
that not all AIs have access to IHS services because of tribal enrollment standards.
Women felt that because less attention is paid to CRC than to breast cancer or diabetes, CRC
is not seen as serious. Participants said other health conditions get more attention from
mainstream media, whether specific to AI or to the general public, and that public health
messages focus on other conditions. Participants agreed that the prominence of discussion
about other diseases and conditions, for example, alcoholism and diabetes, by clinicians and
through public health messages and popular media, deemphasizes CRC education.
Participants noted that this results in low enthusiasm for staying current with screening
guidelines.
Though most women reported discussing CRC with their health care providers and viewed
the discussions in a positive light, women did not always adhere to provider
recommendations for screening. Some women reported a sense of satisfaction with their
provider's communication concerning CRC screening and appreciated conversations about
screening; however, some women felt trepidation toward the topic.
Many women reported that their conversations with providers often did not result in actual
screenings for several reasons. One woman described receiving an FOBT kit but she had yet
to collect and send in her stool sample, saying she was, “just afraid to do it.” For others, the
price of the test was prohibitive, regardless of provider recommendation.
Other priorities (or logistical realities) were described as taking precedence over screening
as well, that is, child care duties, work schedules, long wait periods, and lack of
transportation. Depending on location, contract health services was described as posing
another issue for women living outside of the county with services. For example, a woman
who lives in a different county than that of the IHS facility to which she goes, will not be
able to use contract health for a colonoscopy because the contractual services are only
provided in-county.
Colorectal cancer was not widely discussed with the exception of family and friends who
have a history of or known risk factors associated with CRC. Women explained that some
topics are not discussed in the Native community; CRC is not discussed due to the nature of
screening procedures and the body parts involved. CRC was described as not coming up in
casual conversation unless someone had experienced or been affected by it. Most
participants acknowledged that current attitudes and behaviors concerning CRC needed to
change to increase awareness and screenings.
However, some women reported engaging in conversations regarding CRC with others.
These situations occurred usually because they or someone they knew had been affected by
CRC. Conversations about CRC knowledge were described as being based on personal
experience and when these experiences were shared, others were encouraged to get
screened. Women said they try to influence others to get screened by focusing on the
detrimental effects if people go unscreened.
Women described a need for a comprehensive approach to CRC education and screening,
similar to what has been done for breast cancer. They felt education must include
information specific to Native people, should be tied to social support networks, and should
be inter-generational. They suggested an aggressive campaign for CRC screening that
acknowledged cultural views about CRC and certain key components. First, women
believed that education should contain information specific to Native people and culturally
tailored so that it would be more relevant to them. Participants thought women would be
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better able to make informed decisions if they had appropriate information about screening
methods and in the context of familial risk for CRC. Second, women thought that education
should be tied to social support networks because education and screenings may be
facilitated through family and friends. Third, women suggested that education be
intergenerational. Women felt that involving younger people represented a critical channel
for promoting health because younger generations can learn from elders and make changes
to decrease mortality and improve screening.
Participants were frustrated with screening, referrals, and follow-up in both the IHS and
other health care settings. Many of the complaints stemmed from systematic challenges
within the health care system. The problems reported range from accessing IHS services to
IHS not having the necessary screening services. For example, IHS may not provide
colonoscopies; therefore, individuals may need to rely on contract health. Participants
reported that referrals through contract health do not imply a speedy, worry-free process. It
can be confusing and frustrating for both providers and patients, with problems in
scheduling appointments, long waits for appointments once they are scheduled, and poor
tracking and reporting of test results. These problems make it less likely for patients to
follow through with any appointments using contract health. However, the descriptions
about contract health and IHS were not specific to CRC. Problems were described when
someone needs a test and when coordination of care is necessary.
Participants described how screenings needed coordination on several levels. In the
following example, a woman described a typical experience with health services:
Well, but my Nation would cover it except I'd have to go down there and live in a
motel room while everything is being done and if you don't have the money to do
that . . . [the test will not happen].
This experience illustrated the point that even if health services are available, patients may
not use them because of unanticipated costs.
Discussion
Participants offered insights into exploring and testing new strategies for increasing
screenings among AIs. They described CRC knowledge among AIs as inadequate and
expressed concern that more was not being done to raise awareness and spread the word.
Women incorporated an underlying narrative into the structure of their responses: a lack of
dialogue concerning CRC among the AI community. A relationship between basic
knowledge and lack of communication was described. Women reiterated that lack of
knowledge may feed into a cycle of inadequate communication among community
members.
Participants’ concerns around knowledge led to discussions and suggested strategies for
improving screening rates. A culturally tailored approach to education was suggested.
Current screening and informational messages were described as lacking culturally
appropriate detail. Intergenerational approaches for education were also suggested.
Another important concept described by participants related to use of IHS and the
complexity of dealing with the health care system. The unique problems and challenges of
dealing with IHS and contract health were seen as a major barrier to expanding uptake of
CRC screening. Specific suggestions for improving this situation were not generally offered,
but it was clear that current inadequate access to screening could be improved.
Study conclusions are limited by our use of a regionally recruited sample. Themes may be
unique to AI in the Central Plains. Also, the majority of information given during the focus
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groups concerned IHS or contract health. Few conversations addressed the influence of
private health insurance. Finally, even though all participants self-identified as Native, the
groups contained a heterogeneous population. Not all Native populations are the same,
though most recognize some shared cultural identity. Therefore, the process of reaching
consensus may have been more difficult because of the diversity of participants.
In sum, our research findings provide discrete areas of concern and suggestions for future
approaches to enhance CRC screening. These results informed a research grant (R01
CA158238-01, PI: KAG) that focuses on CRC screening among AI communities via a
tailored touch screen computer intervention. In addition, these results are being incorporated
into culturally appropriate brochures that target AI and CRC screening (P20 MD004805,
PIs: CMD, KAG). These brochures will be designed to meet the needs of the local
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Appendix
Focus Group Moderator's Guide
1. First, what comes to mind when I say colon cancer? What have you heard about it,
if anything?
• Who might be more likely to get it?
• What kinds of symptoms should you look for?
• Is it preventable?
• Is it more or less deadly than other cancers?
• Do you feel like you're at risk for it?
2. Have you ever talked about colon cancer with anyone besides your doctor or other
health care provider? Who? What did you say?
3. Do you think people talk about colon cancer much?
• What about compared to other cancers?
• Is this even something people think about?
• Would it be useful to have some educational materials? What kind(s)?
4. Have you ever talked with your doctor about colon cancer? What did s/he say?
5. If unscreened: Were you ever told to be screened or tested for colon cancer? What
kind of testing?
• FOBT/stool cards, sigmoidoscopy, colonos-copy, double-contrast barium
enema?
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6. If screened: What kind of testing did your doctor recommend you have? What kind
of testing did you have? Why did you choose that one?
7. Do you know anyone who has been tested (other than you)? Have you talked with
him/her about it? What did s/he say?
8. Do you think a lot of Native people get screened for colon cancer? About how
many people in this area get screened? (nobody, few, half, most, everybody)
9. Where do people get screened?
Biography
Melissa K. Filippi, PhD is a research instructor in the Departments of Family Medicine and
Preventive Medicine and Public Health and the Center for American Indian Community
Health at the University of Kansas Medical Center. Her research interests are community-
based participatory research, community health, and health disparities.
Aimee S. James, PhD, MPH is an assistant professor in the Department of Surgery at
Washington University in St. Louis. Her research focuses on health disparities in cancer
prevention and control.
Sarah Brokenleg, MSW is a project coordinator for the Native American Scholars Program
at the Sanford School of Medicine, University of South Dakota.
Myrietta Talawyma is a research technician for the Center for American Indian
Community Health.
David G. Perdue, MD, MSPH is a gastroenterologist at the Masonic Cancer Center,
University of Minnesota. His research focuses on gastrointestinal cancer disparities among
American Indian and Alaska Native populations. He co-chairs both the Minnesota
Colorectal Cancer Task Force and the Minnesota Intertribal Colorectal Cancer Council.
Won S. Choi, PhD, MPH is an associate professor in the Department of Preventive
Medicine and Public Health and the Center for American Indian Community Health at the
University of Kansas Medical Center. His research interests are chronic disease
epidemiology, behavioral epidemiology, and epidemiologic methods. He is the executive
director of the University of Kansas Master of Public Health Program.
K. Allen Greiner, PhD, MPH is a professor in the Departments of Family Medicine and
Preventive Medicine and Public Health and the Center for American Indian Community
Health at the University of Kansas Medical Center. His research interests are cancer
screening and health disparities. He is the director of Family Medicine's Research Division.
Christine M. Daley, PhD, MA, SM is an associate professor in the Departments of Family
Medicine and Preventive Medicine and Public Health at the University of Kansas Medical
Center. Her research focuses on cancer screening and health disparities among American
Indians. She is the director of the Center for American Indian Community Health.
References
1. American Cancer Society. Cancer Facts & Figures 2010. American Cancer Society; Atlanta, GA:
2010.
2. Rim SH, Seeff L, Ahmed F, King JB, Coughlin SS. Colorectal cancer incidence in the United States,
1999-2004: an updated analysis of data from the National Program of Cancer Registries and the
Filippi et al. Page 7













Surveillance, Epidemiology, and End Results Program. Cancer. 2009; 115:1967–1976. [PubMed:
19235249]
3. Perdue D, Perkins C, Jackson-Thompson J, et al. Regional differences in colorectal cancer
incidence, stage, and subsite among American Indians and Alaska Natives, 1999-2004. Cancer.
2008; 113(5 suppl):1179–1190. [PubMed: 18720388]
4. Centers for Disease Control and Prevention. Cancer mortality among American Indians and Alaska
Natives—United States, 1994-1998. MMWR Morb Mortal Wkly Rep. 2003; 52(30):704–707.
[PubMed: 12894057]
5. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic
status. CA Cancer J Clin. 2004; 54:78–93. [PubMed: 15061598]
6. Swan J, Edwards BK. Cancer rates among American Indians and Alaska Natives: is there a national
perspective? Cancer. 2003; 98:1262–1272. [PubMed: 12973851]
7. Yankaskas B, Knight K, Fleg A, Rao C. Misclassification of American Indian race in state cancer
data among non-federally recognized Indians in North Carolina. J Registry Manag. 2009; 36:7–11.
[PubMed: 19670692]
8. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial
screening for fecal occult blood. J Natl Cancer Inst. 1999; 91:434–437. [PubMed: 10070942]
9. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and
colorectal cancer mortality. J Natl Cancer Inst. 1992; 84:1572–1575. [PubMed: 1404450]
10. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-
blood screening for colorectal cancer. Lancet. 1996; 348:1472–1477. [PubMed: 8942775]
11. Pandhi N, Guadagnolo BA, Kanekar S, Petereit DG, Smith MA. Cancer screening in Native
Americans from the Northern Plains. Am J Prev Med. 2010; 38:389–395. [PubMed: 20307807]
12. Holm JE, Vogeltanz-Holm N, Poltavski D, McDonald L. Assessing health status, behavioral risks,
and health disparities in American Indians living on the northern plains of the U.S. Public Health
Rep. 2010; 125:68–78. [PubMed: 20402198]
13. Steele CB, Cardinez CJ, Richardson LC, Tom-Orme L, Shaw KM. Surveillance for health
behaviors of American Indians and Alaska Natives—findings from the Behavioral Risk Factor
Surveillance System, 2000-2006. Cancer. 2008; 113:1131–1141. [PubMed: 18720374]
14. Guadagnolo BA, Cina K, Helbig P, et al. Assessing cancer stage and screening disparities among
Native American cancer patients. Public Health Rep. 2009; 124:79–89. [PubMed: 19413030]
15. Schumacher MC, Slattery ML, Lanier AP, et al. Prevalence and predictors of cancer screening
among American Indian and Alaska native people: the EARTH study. Cancer Causes Control.
2008; 19:725–737. [PubMed: 18307048]
16. Crawley LM, Ahn DK, Winkleby MA. Perceived medical discrimination and cancer screening
behaviors of racial and ethnic minority adults. Cancer Epidemiol Biomarkers Prev. 2008;
17:1937–1944. [PubMed: 18687583]
17. Whitbeck LB, McMorris BJ, Hoyt DR, Stubben JD, Lafromboise T. Perceived discrimination,
traditional practices, and depressive symptoms among American Indians in the Upper Midwest. J
Health Soc Behav. 2002; 43:400–418. [PubMed: 12664673]
18. Daley CM, James A, Filippi M, et al. American Indian community leader and provider views of
needs and barriers to colorectal cancer screening. J Health Disparities Res Pract. 2012; 5(2) Article
2.
19. Daley CM, James AS, Ulrey E, et al. Using focus groups in community-based participatory
research: challenges and resolutions. Qual Health Res. 2010; 20:697–706. [PubMed: 20154299]
Filippi et al. Page 8

























Filippi et al. Page 9
Table 1
Demographic Information
American Indian Elder Women (N = 52)
Frequency Percentage
Current living situation
    Married/partner 24 46.2
    Divorced/widowed 23 44.2
    Never married 5 9.6
Education
a
    Some high school 3 5.9
    High school graduate/GED 11 21.6
    Some college 17 33.3
    AA degree 6 11.8
    BA/BS degree or higher 14 27.4
Health insurance outside of Indian Health Service
    No 7 13.5
    Yes 45 86.5
Where do you receive the majority of your health care?
a
    Indian Health Service 21 42.9
    Other health care facility 28 57.1
Have you ever talked with your doctor about colon cancer testing?
a
    No 15 29.4
    Yes 35 68.6
    Not sure 1 2.0
Have you ever been told by a doctor or nurse that you had a cancer other than colorectal cancer?
a
    No 36 72.0
    Yes 14 28.0
Have you or any of your blood relatives ever been diagnosed with colon polyps by a doctor or nurse?
a
    No 22 48.9
    Yes 19 42.2
    Not sure 4 8.9
Have you or any of your blood relatives ever been diagnosed with colorectal cancer?
    No 27 51.9
    Yes 19 36.5
    Not sure 6 11.5
Did you or your family member receive treatment for colorectal cancer?
a
    No 8 42.1
    Yes 7 36.8
    Not sure 4 21.1
a
Not all participants responded.
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Table 2
Screening History
Women 50+ Years Old (N = 52)
n Percentage
Discussed colorectal cancer testing
    No 15 30
    Yes 35 70
Fecal occult blood test (FOBT)
Ever had a FOBT
    No 22 44
    Yes 28 56
Most recent FOBT
    ≤1 year 7 25
    1-2 years 4 14.2
    2-5 years 11 39.2
    >5 years 6 21.4
Reason for most recent FOBT
    Routine exam 22 78.5
    Symptom/follow-up 6 21.4
Sigmoidoscopy
Ever had a sigmoidoscopy
    No 36 72
    Yes 14 28
Most recent sigmoidoscopy
    ≤ 1 year or less 1 8.3
    1-2 years 2 16.6
    2-5 years 2 16.6
    >5 years 7 58.3
Reason for most recent sigmoidoscopy
    Routine exam 9 75
    Symptom/follow-up 3 25
Colonoscopy
Ever had a colonoscopy
    No 22 43.1
    Yes 29 56.8
Most recent colonoscopy
    <2 years 9 32.1
    2-5 years 13 46.4
    5-10 years 5 17.8
    >10 years 1 3.5
Reason for most recent colonoscopy
    Routine exam 18 64.2
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Women 50+ Years Old (N = 52)
n Percentage
    Symptom/follow-up 10 35.7
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